Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Treasury Shares: 2018-2025

Historic Treasury Shares for Whitehawk Therapeutics (WHWK) over the last 3 years, with Sep 2025 value amounting to $2.4 million.

  • Whitehawk Therapeutics' Treasury Shares rose 655.30% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 655.30%. This contributed to the annual value of $256,490 for FY2024, which is 687.79% up from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Treasury Shares of $2.4 million as of Q3 2025, which was down 0.00% from $2.4 million recorded in Q2 2025.
  • Whitehawk Therapeutics' Treasury Shares' 5-year high stood at $2.4 million during Q2 2025, with a 5-year trough of $32,558 in Q4 2023.
  • Over the past 3 years, Whitehawk Therapeutics' median Treasury Shares value was $325,628 (recorded in 2024), while the average stood at $779,756.
  • In the last 5 years, Whitehawk Therapeutics' Treasury Shares soared by 687.79% in 2024 and then slumped by 52.61% in 2025.
  • Quarterly analysis of 3 years shows Whitehawk Therapeutics' Treasury Shares stood at $32,558 in 2023, then skyrocketed by 687.79% to $256,490 in 2024, then soared by 655.30% to $2.4 million in 2025.
  • Its Treasury Shares stands at $2.4 million for Q3 2025, versus $2.4 million for Q2 2025 and $161,721 for Q1 2025.